Board Login / Members Only
The Center for Psychiatric Oncology & Behavioral Sciences in the Department of Psychiatry of Massachusetts General Hospital (MGH) / Harvard Medical School (HMS) is seeking a Clinical Psychology Postdoctoral Research Fellow for two years. The postdoctoral fellow will also be a member of the Cancer Outcomes Research & Education (CORE) Program in the MGH Cancer Center. The fellow will be eligible for two years of salary (competitive) support through one MGH-funded and one NIH-funded grant. They will have an academic appointment at HMS and should have completed the requirements for their Ph.D. Ideal applicants are those who plan to transition to an academic position after the fellowship period. The fellow will devote 80-85% of effort to psychosocial oncology/cancer outcomes research and 15-20% to clinical work and supervision in the psychiatric oncology service. Supervised hours for licensure are assured, as is a wealth of opportunities for multidisciplinary research collaboration and extensive mentorship. A successful candidate will have a strong demonstrated interest and experience in clinical intervention research in psychosocial oncology and cancer outcomes, and those with experience working with people with different types of cancer, their family and/or friend caregivers, cancer survivors, or those at end-of-life are encouraged to apply.
For the full position announcement contact Jamie Jacobs, PhD at [email protected].
PSYCHO-ONCOLOGY PSYCHOLOGY FACULTY POSITION
MEMORIAL SLOAN-KETTERING (MSK) CANCER CENTER invites applications for a full-time psychologist position in the Department of Psychiatry and Behavioral Sciences. This faculty position will focus primarily on clinical care and will also have opportunities for teaching and conducting collaborative research. This position will provide psychological care to MSKs regional sites in Long Island, with an in-person presence one day a week at MSK Nassau and one day a week at MSK Commack. The position will also provide care to patients in Manhattan and will be a mix of in-person and telehealth. Candidates should have clinical experience and appropriate training in working with adult cancer patients and their families. This position will work with cancer patients, and their families and caregivers, with a variety of cancer diagnoses and cancer stages. The Department of Psychiatry and Behavioral Sciences currently has over 40 full-time faculty with wide interests in psycho-oncology clinical care, teaching, and research. This search is open to potential candidates at junior levels of career experience and appointments will be made at an academic level commensurate with the appointee’s experience. All faculty hold academic appointments at the Weill Cornell Medical College. Salary is competitive and commensurate with experience. MSKCC provides excellent benefits including faculty housing benefits. MSKCC is an Equal Opportunity /Affirmative Action Employer. Women and minority candidates are encouraged to apply.
Email a cover letter, curriculum vitae, and contact information for at least 3 references to: Christian J. Nelson, PhD Chief, Psychiatry Service Attending Psychologist, Member c/o Laurie Schulman Memorial Sloan Kettering Cancer Center Department of Psychiatry and Behavioral Sciences 641 Lexington Avenue, 7th Floor New York, NY 10022 Email: [email protected]
The 2021 IPOS Members meeting has been scheduled for June 29, 2021 at 8:30 a.m. ET (New York/Toronto). Verify your time zone by going to https://www.timeanddate.com/worldclock/converter.html.
This year, the AGM will be held via Zoom. Access information will be included in registrant confirmation.
As this was an election year as the board, the newly elected board of directors as well as your current board of directors will be present.
To review the IPOS Constitution, please go to https://ipos-society.org/about/organization.
Thanks to all the nominees for the 2021-2023 IPOS Board of Directors. Thanks also to all the IPOS eligible voting members. We had a record-breaking voter response.
The below will the the official board of directors as of June 29 for 2021-2023:
Position Summary:
The Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences at McGill University is accepting applications for a postdoctoral fellow position in research on mental health and social determinants of health in oncology. This position will be based at the Lady-Davis Institute for Medical Research of the Jewish General Hospital. This position offers a unique opportunity to work within a collaborative team-oriented research environment in a world-class facility affiliated with a premier Canadian University. Under the supervision of Dr. Henry, the successful candidate will use longitudinal and experimental methods to study factors and interventions aimed at improving quality of life and reducing health disparities in cancer patients.
EDUCATION
Candidates must hold a recently obtained relevant PhD or equivalent degree, received within the past three years.
QUALIFICATIONS
Familiarity and/or experience with longitudinal studies, interventional studies, and randomized controlled trials;
Background in oncology or chronic medical conditions;
Excellent organizational skills and the ability to work independently, while contributing to the efforts of a larger research team;
Ability to design and carry out research independently;
Exceptional computational skills;
Excellent verbal and written communication skills in English.
The candidates will be expected to give oral presentations and take part in writing manuscripts, grant proposals, and project reports. The Lady-Davis Institute (LDI) for Medical Research of the Jewish General Hospital is affiliated with the Faculty of Medicine and Health Sciences of McGill University. The LDI campus offers an outstanding scientific and patient-oriented research environment with state-of-the-art facilities.
For additional information related to the application as a post-doctoral fellow at McGill University, please refer to: https://www.mcgill.ca/gps/postdocs/fellows/registration/eligibility. A postdoctoral trainee cannot register (or remain registered) with McGill’s Graduate and Postdoctoral Studies if 5 or more years have elapsed since their PhD or equivalent degree.
Supervisor: Dr. Melissa Henry (Associate Professor)
Work Location: Lady-Davis Institute for Medical Research of the Jewish General Hospital
Position Start Date: As soon as possible
Position End Date: 2 years duration
Annual Salary: Salary is $45,000/annum (Full-time: 35-hour per week)
100 FORwards members!
Earlier this month, we reached our 100th FORwards SIG member. Daelin Coutts-Bain, our 100th member, is a PhD student at the University of Sydney. Daelin’s PhD research is under the supervision of FORwards member Louise Sharpe and focuses on cognitive mechanisms of fear of cancer recurrence and fear of cancer progression. We are thrilled to see our membership grow substantially over the last two years and are looking forward to welcoming more new members in 2021.
Call for New FORwards Committee Members
Are you interested in and passionate about contributing to fear of cancer recurrence research at a global level? The IPOS FORwards SIG committee for 2021-2023 will be formed at the IPOS ASM in May, and we are looking for new representatives. There are four open positions:
Please contact the FORwards secretary, Lauren Heathcote, at [email protected] to nominate yourself or another FORwards member.
Two new FORwards Webinar Recordings, Now Available Online
Since the last update, we held two more webinars as part of the Fear of Recurrence Webinar Series: Group-based Interventions for Fear of Cancer Recurrence (December 2020) and Innovations in Screening for Fear of Cancer Recurrence and Progression (March 2021). Each webinar was attended by over 60 researchers and clinicians from around the world. The full recordings are now available through the IPOS website and are free to current IPOS members or $15 USD for non-members: https://www.ipos-society.org/webcasts
Conquer Fear Masterclass in Russia
Congratulations to FORwards member Evgeniia Ananeva, who led the successful launch of a new training program for clinicians to deliver the Conquer Fear intervention in Russia. The adaptation of the Conquer Fear materials into Russian was made possible through a collaboration between several FORwards members, including Phillis Butow, Jane Turner, Sébastien Simard, and Tania Estape. For those interested in learning more about the Conquer Fear intervention, and other interventions to reduce fear of cancer recurrence, there will be a workshop on treating FCR at the upcoming IPOS ASM.
FCR Research
FORwards members have been hard at work publishing new papers on fear of cancer recurrence and progression over the last few months. Below is a small selection of new papers from our SIG members.
Gormley, M., Knobf, T., Vorderstrasse, A., Aouizerat, B., Hammer, M., Fletcher, J., & D’Eramo Melkus, G. (2020). Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors. Psycho‐Oncology.
Braun, S. E., Aslanzadeh, F. J., Thacker, L., & Loughan, A. R. (2021). Examining Fear of Cancer Recurrence in Primary Brain Tumor Patients and Their Caregivers Using the Actor‐Partner Interdependence Model. Psycho‐Oncology.
Cunningham, S. J., Patton, M., Schulte, F., Richardson, P. A., & Heathcote, L. C. (2021). Worry about somatic symptoms as a sign of cancer recurrence: prevalence and associations with fear of recurrence and quality of life in survivors of childhood cancer
Pradhan, P., Sharpe, L., Butow, P. N., Smith, A. B., & Russell, H. (2021). Is a brief online booklet sufficient to reduce fear of cancer recurrence or progression in women with ovarian cancer?. Frontiers in Psychology, 12.
Shaw, J., Kamphuis, H., Sharpe, L., Lebel, S., Smith, A. B., Hulbert-Williams, N. J., ... & Butow, P. N. (2021). Setting an International Research Agenda for Fear of Cancer Recurrence: an online delphi consensus study. Frontiers in psychology, 12, 241.
If you would like to include an update in the Spring newsletter, or know a student or colleague who would like to join this SIG, please reach out to Lauren Heathcote (FORwards Secretary) at [email protected].
Thank you all for the phenomenal work that you do to support people living with and beyond cancer.
Kind regards,
Your FORwards committee
Chair: Ben Smith
Deputy Chair: Marije van der Lee
Secretary: Lauren Heathcote
Early Career Rep: Brittany Mustaers
Training in Russia on "How to help patients to cope with FCR" was held virtually in January 2021. There were 15 participators from across Russia, from Komsomolsk-on-Amur (Far East) to Moscow. The program consisted of two days of online theory and practice masterclasses. All attendees work with patients and help them to grapple with FCR, online and face-to-face in their cities. Help was appreciated from: Phillis Butow and Jane Turner who provided additional materials that helped to create the practice part of the training. Sebastien Simard for provider permission to translate into Russian and use the FCRI. Tania Estapé for helping create this training for Russian psychologists. Best regards, Evgeniia Ananeva
Training in Russia on "How to help patients to cope with FCR" was held virtually in January 2021.
There were 15 participators from across Russia, from Komsomolsk-on-Amur (Far East) to Moscow. The program consisted of two days of online theory and practice masterclasses. All attendees work with patients and help them to grapple with FCR, online and face-to-face in their cities.
Help was appreciated from:
Best regards, Evgeniia Ananeva
Thursday, April 29, 2021, 8 to 9 p.m. ET Live webcast via Zoom
Featuring: Dr Maria Ftanou
Dr Maria Ftanou is the head of the Clinical Psychology Department at the Peter MacCallum Cancer Centre in Melbourne and a Research Fellow at the School of Population and Global Health at The University of Melbourne. Maria has over 17 years of clinical experience, primarily in the field of psychosocial oncology. She and her team provide evidence-based psychological interventions to people with cancer and their families across the cancer trajectory.
Advanced registration is required. This event is LIVE. Be sure to check your local time zone by going to https://www.timeanddate.com/worldclock/converter.html
Register online by going to https://ipos-society.org/event-4213024
SPECIAL INSTRUCTIONS:
Cancer Coaching Professional Certificate
This online certificate is developed for health professionals who want to help clients effectively self-manage care, across phases in the cancer continuum. Develop skills as a cancer coach to engage and motivate cancer populations to improve disease outcomes and health recovery.
This program is offered by the Health Leadership & Learning Network , which offers lifelong learning for health and social service staff and managers within the Faculty of Health at York University in Canada.
Webinar Innovations in screening and assessment of fear of cancer recurrence and progression
Date March 12, 2021 (-1 day for those outside of Australia/NZ) Time 8:30am AEDT (convert to your local time) Duration 60 minutes
Speakers Ben Smith, PhD, University of New South Wales Yasmin Youssef, PhD, University Medical Centre Leipzig Daelin Coutts-Bain, University of Sydney Moderator Louise Sharpe, PhD, University of Sydney
The FORwards Webinar Series aims to bring together the international community of researchers and clinicians interested in fear of cancer recurrence, to provide cutting-edge updates on brand-spanking new research, and to spark conversations and collaborative projects across the globe.
This webinar will be of interest to both clinicians and researchers who want to better understand and manage FCR in people living with cancer and their loved ones.
Attendance is free, but registration is required
Register online by going to https://stanford.zoom.us/webinar/register/WN_ilEr5MwSR-O2PVzU3pebeQ
International Psycho-Oncology Society1 - 189 Queen Street East Toronto, ON M5A 1S2
244 Fifth Avenue, Suite L296 New York, NY 10001
T: +1 416-968-0260 [email protected]
Sitemap
© 2025 International Psycho-Oncology Society
Website powered by Funnel Communications Inc.
